Literature DB >> 14982746

Signaling pathways to neuronal damage and apoptosis in human immunodeficiency virus type 1-associated dementia: Chemokine receptors, excitotoxicity, and beyond.

Marcus Kaul1, Stuart A Lipton.   

Abstract

Dementia can occur as a debilitating consequence of human immunodeficiency virus-1 (HIV-1) infection. The neuropathology incited by HIV infection involves activation of chemokine receptors, inflammatory factors, and N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity, all of which can activate several downstream mechanisms. This article discusses recently identified pathways to neuronal damage triggered by HIV-1 and efforts aimed at development of applicable therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982746     DOI: 10.1080/753312759

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  33 in total

Review 1.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.

Authors:  S L Letendre; E R Lanier; J A McCutchan
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

3.  Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein.

Authors:  R Sattler; Z Xiong; W Y Lu; M Hafner; J F MacDonald; M Tymianski
Journal:  Science       Date:  1999-06-11       Impact factor: 47.728

4.  The contribution of various NOS gene products to HIV-1 coat protein (gp120)-mediated retinal ganglion cell injury.

Authors:  E B Dreyer; D Zurakowski; M Gorla; C K Vorwerk; S A Lipton
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-04       Impact factor: 4.799

5.  Caspase cascades in human immunodeficiency virus-associated neurodegeneration.

Authors:  Gwenn A Garden; Samantha L Budd; Elena Tsai; Lisa Hanson; Marcus Kaul; Danielle M D'Emilia; Robert M Friedlander; Junying Yuan; Eliezer Masliah; Stuart A Lipton
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

6.  Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.

Authors:  D E Brenneman; G L Westbrook; S P Fitzgerald; D L Ennist; K L Elkins; M R Ruff; C B Pert
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

7.  Expression of stromal cell-derived factor 1alpha protein in HIV encephalitis.

Authors:  Dianne Langford; Virginia J Sanders; Margaret Mallory; Markus Kaul; Eliezer Masliah
Journal:  J Neuroimmunol       Date:  2002-06       Impact factor: 3.478

8.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1.

Authors:  D Giulian; K Vaca; C A Noonan
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

9.  Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.

Authors:  A Ohagen; S Ghosh; J He; K Huang; Y Chen; M Yuan; R Osathanondh; S Gartner; B Shi; G Shaw; D Gabuzda
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats.

Authors:  J M Galasso; J K Harrison; F S Silverstein
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  8 in total

1.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

Review 2.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

Review 3.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

4.  Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.

Authors:  Walter Royal; Li Zhang; Ming Guo; Odell Jones; Harry Davis; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2012-04-12       Impact factor: 3.478

5.  Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS.

Authors:  Dima A Hammoud; Christopher J Endres; Ankit R Chander; Tomas R Guilarte; Dean F Wong; Ned C Sacktor; Justin C McArthur; Martin G Pomper
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

Review 6.  Neuroprotective strategies for HIV-1 associated dementia.

Authors:  Huanyu Dou; Jeffrey D Kingsley; R Lee Mosley; Harris A Gelbard; Howard E Gendelman
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes.

Authors:  Suman Jayadev; Bomy Yun; Huy Nguyen; Hideaki Yokoo; Richard S Morrison; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-20       Impact factor: 4.147

8.  HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanisms.

Authors:  Manmeet K Mamik; Sugato Banerjee; Timothy F Walseth; Renee Hirte; Lin Tang; Kathleen Borgmann; Anuja Ghorpade
Journal:  J Neuroinflammation       Date:  2011-10-25       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.